NEWS

Dec 12, 2022

UNC researchers report protective effects of parmodulins in sickle cell disease models

A collaborative team led by Prof. Erica Sparkenbaugh from the Univ. of North Carolina Blood Research Center reported at the 64th American...

Nov 12, 2022

Peter Suzdak, Ph.D. joins as consultant

Peter Suzdak, Ph.D. has joined Function Therapeutics, Inc. as a consultant. Dr. Suzdak has deep scientific and management successes in...

Sep 29, 2022

ML161 greatly improves kidney function in a mouse model of diabetic kidney disease

Drs. Shrey Kohli, Berend Isermann, and team report in Nature Communications that the PAR1-targeting parmodulin ML161 (aka Parmodulin 2)...